18F-FTC-146

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
206	脆弱Ｘ症候群	1

206. 脆弱Ｘ症候群

臨床試験数 : 108 / 薬物数 : 91 - (DrugBank : 36) / 標的遺伝子数 : 52 - 標的パスウェイ数 : 77

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04314856 (ClinicalTrials.gov)	January 12, 2021	11/3/2020	Novel Clinical Target in Fragile X Syndrome	Sigma-1 Receptors: A Novel Clinical Target in Fragile X Syndrome	Fragile X Syndrome (FXS)	Drug: 18F-FTC-146	Guido A. Davidzon, MD, SM	NULL	Withdrawn	18 Years	65 Years	All	0	Phase 1	United States